These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 24835166)

  • 1. Superficial abdominal thrombophlebitis (Mondor's disease) presenting as loss of response to adalimumab in a Crohn's disease patient.
    Ben-Horin S; Lubetsky A; Heyman Z; Kleinbaum Y
    J Crohns Colitis; 2014 Nov; 8(11):1557-8. PubMed ID: 24835166
    [No Abstract]   [Full Text] [Related]  

  • 2. The pharmacokinetic effect of adalimumab on thiopurine metabolism in Crohn's disease patients.
    Wong DR; Pierik M; Seinen ML; van Bodegraven AA; Gilissen LP; Bus P; Bakker JA; Masclee AA; Neef C; Engels LG; Hooymans PM
    J Crohns Colitis; 2014 Feb; 8(2):120-8. PubMed ID: 23932783
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Crohn's disease outpatients treated with adalimumab have an earlier secondary loss of response and requirement for dose escalation compared to infliximab: a real life cohort study.
    Ma C; Huang V; Fedorak DK; Kroeker KI; Dieleman LA; Halloran BP; Fedorak RN
    J Crohns Colitis; 2014 Nov; 8(11):1454-63. PubMed ID: 24947334
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Psychotic reaction as a cardinal first clinical manifestation in a patient with Crohn's disease.
    Triantafillidis JK; Vagianos K; Rontos I
    J Crohns Colitis; 2013 Mar; 7(2):e76-7. PubMed ID: 22854290
    [No Abstract]   [Full Text] [Related]  

  • 5. Frequency and predictors of loss of response to infliximab or adalimumab in Crohn's disease after one-year treatment period - a single center experience.
    Molnár T; Farkas K; Nyári T; Szepes Z; Nagy F; Wittmann T
    J Gastrointestin Liver Dis; 2012 Sep; 21(3):265-9. PubMed ID: 23012667
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute coronary syndrome in a Crohn's disease patient treated with adalimumab.
    Petitpain N; Bornert-Keller N; Peyrin-Biroulet L
    J Crohns Colitis; 2013 Oct; 7(9):e396. PubMed ID: 23523265
    [No Abstract]   [Full Text] [Related]  

  • 7. Adalimumab or infliximab for the prevention or treatment of post-operative recurrence in Crohn's disease.
    Yamamoto T
    J Crohns Colitis; 2013 May; 7(4):e157. PubMed ID: 23021875
    [No Abstract]   [Full Text] [Related]  

  • 8. Sarcoidosis complicating treatment with adalimumab for Crohn's disease.
    McDonnell MJ; Rutherford RM; O'Regan A
    J Crohns Colitis; 2014 Sep; 8(9):1140-1. PubMed ID: 24631310
    [No Abstract]   [Full Text] [Related]  

  • 9. The influence of infliximab and adalimumab on the expression of apoptosis-related proteins in lamina propria mononuclear cells and enterocytes in Crohn's disease - an immunohistochemical study.
    Eder P; Lykowska-Szuber L; Krela-Kazmierczak I; Stawczyk-Eder K; Zabel M; Linke K
    J Crohns Colitis; 2013 Oct; 7(9):706-16. PubMed ID: 23021876
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adalimumab for a co-existing clinical condition of Crohn's disease and acrodermatitis continua of Hallopeau.
    Caputo F; Parro S; Zoli G
    J Crohns Colitis; 2011 Dec; 5(6):649. PubMed ID: 22115391
    [No Abstract]   [Full Text] [Related]  

  • 11. Anti-TNF-alpha treatments and obstructive symptoms in Crohn's disease: a prospective study.
    Condino G; Calabrese E; Zorzi F; Onali S; Lolli E; De Biasio F; Ascolani M; Pallone F; Biancone L
    Dig Liver Dis; 2013 Mar; 45(3):258-62. PubMed ID: 23195667
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adalimumab therapy in children with Crohn disease previously treated with infliximab.
    Cozijnsen M; Duif V; Kokke F; Kindermann A; van Rheenen P; de Meij T; Schaart M; Damen G; Norbruis O; Pelleboer R; Van den Neucker A; van Wering H; Hummel T; Oudshoorn J; Escher J; de Ridder L;
    J Pediatr Gastroenterol Nutr; 2015 Feb; 60(2):205-10. PubMed ID: 25286063
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Efficacy and safety of Adalimumab in Crohn's disease].
    Serghini M; Haddad W; Jeddi H; Karoui S; Ben Mustapha N; Kallel L; Fekih M; Matri S; Boubaker J; Filali A
    Tunis Med; 2012 Feb; 90(2):101-7. PubMed ID: 22407620
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Severe adalimumab-induced thrombocytopenia in a patient with Crohn's disease.
    Casanova MJ; Chaparro M; Martínez S; Vicuña I; Gisbert JP
    J Crohns Colitis; 2012 Dec; 6(10):1034-7. PubMed ID: 22534313
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effectiveness of anti-TNF alpha antibodies in treatment of fistulizing Crohn's disease].
    Rozpondek P; Zwolińska-Wcisło M; Przybylska M; Mach T
    Przegl Lek; 2011; 68(9):602-5. PubMed ID: 22335009
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adalimumab for Crohn's disease with intolerance or lost response to infliximab: a 3-year single-centre experience.
    Oussalah A; Babouri A; Chevaux JB; Stancu L; Trouilloud I; Bensenane M; Boucekkine T; Bigard MA; Peyrin-Biroulet L
    Aliment Pharmacol Ther; 2009 Feb; 29(4):416-23. PubMed ID: 19035976
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sjögren's syndrome associated with Crohn's disease successfully treated with adalimumab.
    Tursi A
    J Crohns Colitis; 2012 Mar; 6(2):263. PubMed ID: 22325185
    [No Abstract]   [Full Text] [Related]  

  • 18. Adalimumab for perianal fistulizing Crohn's disease: real-world data adds important information for clinical practice.
    Kotze PG; Spinelli A
    J Clin Gastroenterol; 2015 Feb; 49(2):174-5. PubMed ID: 25159683
    [No Abstract]   [Full Text] [Related]  

  • 19. Ultrasound diagnosis of three cases of Mondor's disease.
    Machan K; Rojo-Carmona LE; Marquez-Moreno AJ; Herrera-Imbroda B; Ruiz-Escalante JF; Herrera-Gutierrez D; Acebal-Blanco MM
    Arch Esp Urol; 2012 Mar; 65(2):262-6. PubMed ID: 22414457
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Use of adalimumab in a patient with Crohn's disease and extensive generalised psoriasis who achieved complete remission of both conditions].
    Piqueras M; Monfort D; Pol MA; Galter S; Modolell I; Ortiz J; Boadas J
    Gastroenterol Hepatol; 2013; 36(6):396-9. PubMed ID: 23587662
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.